Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Trevi Therapeutics, Inc. | Chief Financial Officer | Common Stock | 53.3K | $141K | $2.64 | May 22, 2024 | Direct |
Trevi Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 48.1K | May 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRVI | Trevi Therapeutics, Inc. | May 22, 2024 | 3 | -$3.29K | 4 | May 24, 2024 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Feb 15, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Oct 11, 2023 | 3 | -$414 | 4 | Oct 12, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Sep 11, 2023 | 3 | -$393 | 4 | Sep 13, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Aug 11, 2023 | 3 | -$438 | 4 | Aug 14, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Jul 11, 2023 | 3 | -$436 | 4 | Jul 12, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Jun 12, 2023 | 3 | -$440 | 4 | Jun 14, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | May 11, 2023 | 3 | -$453 | 4 | May 15, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Apr 11, 2023 | 3 | -$374 | 4 | Apr 12, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Mar 13, 2023 | 3 | -$393 | 4 | Mar 15, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Feb 16, 2023 | 1 | $0 | 4 | Feb 16, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Feb 13, 2023 | 3 | -$6.71K | 4 | Feb 15, 2023 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Feb 11, 2022 | 1 | $0 | 4 | Feb 15, 2022 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Aug 9, 2021 | 1 | $0 | 4 | Aug 9, 2021 | Chief Financial Officer |
TRVI | Trevi Therapeutics, Inc. | Aug 9, 2021 | 0 | $0 | 3 | Aug 9, 2021 | Chief Financial Officer |